Pharmacy giant CVS will pay $1.95 million and verify that all of its pharmacists are licensed in Indiana to settle a state
complaint that pharmacists with expired licenses dispensed prescriptions for several years at two of its drugstores.
VoCare Inc. wants $4 million in cash and tax incentives to open headquarters and call center it says could employ 300 people.
The Health & Hospital Corp. of Marion County got good news in its first round of borrowing to finance a new Wishard
hospital: The cost is less than expected.
Health care real estate has survived the nation’s weak economy better than most sectors, and some owners and developers
think it’s positioned to thrive.
WellPoint Inc. chief financial officer Wayne DeVeydt said President Obama’s Federal Trade Commission is unlikely to approve
mergers among the biggest insurers.
Eli Lilly and Co. CEO John Lechleiter’s total compensation increased $4.1 million in 2009.
Cardinal Health notified the state on Feb. 3 that it laid off 37 workers at the end of January and plans to lay off 12 more
effective April 3.
Employer activism is on the rise when it comes to keeping hospitals honest in their negotiations with health insurers.
Executives at Indianapolis-based WellPoint say more employers are airing their displeasure when hospital
systems ask for double-digit reimbursement increases.
The uncertainty of health care reform and a bad economy curtailed venture capital flow in 2009.
Mississippi will receive $18.5 million from Indianapolis-based drugmaker Eli Lilly and Co. as part of a settlement over claims
the company promoted the anti-psychotic Zyprexa for ailments it was not federally approved to treat.
Batesville maker of hospital equipment meets analysts’ expectations, then raises full-year profit forecast.
Larry Glasscock will step down March 1 as WellPoint CEO Angela Braly takes over leadership of the company’s board. She replaced
Glasscock as CEO on June 1, 2007.
Larry Glasscock will retire as chairman of WellPoint Inc.’s board, the Indianapolis-based health insurer said early Wednesday.
Company CEO Angela Braly will assume the position March 1.
An Indiana University prof thinks Indianapolis should anticipate a future without Indianapolis Motor Speedway, and a potentially
reduced Eli Lilly and Co.
Dr. Kristine Courtney, Eli Lilly and Co.’s senior director of corporate health services, describes
how and why the company spent two years making its clinics some of the first to electronically swap patient records with
a local hospital database.
The uncertainty of health care reform and a bad economy curtailed venture capital flow in 2009. That trend hit Indianapolis,
but the rest of the state actually saw an increase.
Indianapolis-based Dow AgroSciences said Tuesday it posted a profit of $69 million in the fourth quarter, down 19 percent
from the prior year because of increased research and development spending and higher administrative expenses. Revenue was
up 17 percent.
New Jersey-based Enzon Pharmaceuticals Inc. has sold its Indianapolis plant that manufactures specialty drugs in a deal that
could top $300 million. The buyer says that the operations, which employ about 100, will remain in the city.
Greenwood-based Zimmerman Biotechnologies LLC hopes to become the first company in the United States to make generic insulin,
a long-awaited development in diabetes treatment. The Greenwood Common Council on Feb. 1 will consider an $8.4 million deal
that would finance construction of an insulin factory, as well as help Zimmerman with FDA-approval and equipment expenses.
St. Vincent Health is near an agreement to take over The Care Group LLC, the city’s largest independent physician practice
and largest cardiology group in the nation.
